• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Centaur Guernsey

Failure of Medtronic’s Symplicity-3 trial doesn’t mean the end of renal denervation for hypertension | Medtech Wall Street news for the week of September 1, 2014

September 4, 2014 By MassDevice Contributors Network Leave a Comment

Renal denervation isn't dead, despite Medtronic trial's failure

September 2, 2014 by Brad Perriello

Filed Under: News Well, Wall Street Beat Tagged With: Acelity, Apax Partners, Baxter, Boston Scientific, Centaur Guernsey, Covidien, Kinetic Concepts Inc., Kona Medical, LifeCell Corp., ReCor Medical, stjudemedical, Systagenix Wound Management Inc.

Private equity owners rebrand KCI, Systagenix, LifeCell as Acelity

September 3, 2014 By Brad Perriello Leave a Comment

Private equity owners rebrand KCI, Systagenix, LifeCell as Acelity

The private equity owners of a trio of wound care and regenerative medicine companies said today that they’re merging Kinetic Concepts Inc., Systagenix and LifeCell into a single entity called Acelity.

Filed Under: News Well, Regenerative Medicine, Wall Street Beat Tagged With: Acelity, Apax Partners, Centaur Guernsey, Kinetic Concepts Inc., LifeCell Corp., Marketing/Public Relations, Systagenix Wound Management Inc., Wound Therapy

CeQur names medtech veteran as new CEO | Medtech personnel moves for the week of Apr. 14, 2014

April 16, 2014 By MassDevice Contributors Network Leave a Comment

CeQur gets new CEO from Becton Dickinson | Personnel Moves

April 11, 2014 by Arezu Sarvestani

fired/hired

Switzerland-based insulin delivery devices maker CeQur named medtech veteran Douglas Lawrence its new CEO, replacing James Peterson.

Filed Under: News Well Tagged With: becton dickinson, Centaur Guernsey, CeQur SA, Kinetic Concepts Inc., MELA Sciences Inc., Personnel Moves, Tal Medical, Teleflex

CeQur gets new CEO from Becton Dickinson | Personnel Moves

April 11, 2014 By Arezu Sarvestani Leave a Comment

fired/hired

Switzerland-based insulin delivery devices maker CeQur named medtech veteran Douglas Lawrence its new CEO, replacing James Peterson.

Lawrence has spent more than 25 years in the medical device industry, most recently as vice president of the insulin injection business at Becton, Dickinson’s (NYSE:BDX) diabetes arm.

Filed Under: News Well Tagged With: becton dickinson, Centaur Guernsey, CeQur SA, Insulin Management, Kinetic Concepts Inc., MELA Sciences Inc., Personnel Moves, Tal Medical, Teleflex

Kinetic Concepts, LifeCell, Systagenix trio posts red ink in Q4

March 10, 2014 By Arezu Sarvestani Leave a Comment

Kinetic Concepts, LifeCell, Systagenix trio posts red ink in Q4

The newly formed medtech alliance comprised of Kinetic Concepts, LifeCell and Systagenix posted collective figures that put the group in the red for Q4, a recent SEC filing shows.

Filed Under: MassDevice Earnings Roundup, News Well, Regenerative Medicine Tagged With: 2013, Centaur Guernsey, Kinetic Concepts Inc., LifeCell Corp., Q4, Systagenix Wound Management Inc., Wound Therapy

Kinetic Concepts slips in Q3, losses widen for Systagenix, LifeCell triad

November 13, 2013 By Arezu Sarvestani Leave a Comment

Kinetic Concepts announces 1st quarter as part of Centaur Guernsey

Sales took a minor hit for Kinetic Concepts during its 3rd quarter 2013, reporting as part of the Centaur Guernsey companies which now includes both LifeCell and Systagenix.

Filed Under: MassDevice Earnings Roundup, News Well, Regenerative Medicine Tagged With: 2013, Centaur Guernsey, Kinetic Concepts Inc., LifeCell Corp., Q3, Systagenix Wound Management Inc., Wound Therapy

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy